Movectro (cladribine)
- Region
- 🇪🇺 EU
- Active substance
- cladribine
- Company
- Merck Serono Europe Limited
- Status
- Application withdrawn
- Therapeutic area
- Multiple Sclerosis
- Application
- EMEA/H/C/001197
- ATC
- L01BB04
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Mavenclad Authorised · Merck Europe B.V.
- 🇪🇺 Litak Authorised · Lipomed GmbH
Follow Movectro
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.